title: Re-evaluation of toxicity and long-term follow-up of isolated lung perfusion with melphalan in patients with resectable pulmonary metastases: a phase I and extension trial.
authors.forename: Marco J J H
authors.initials: MJ
authors.lastname: Grootenboers
authors.forename: Franz M N H
authors.initials: FM
authors.lastname: Schramel
authors.forename: Wim J
authors.initials: WJ
authors.lastname: van Boven
authors.forename: Bart P
authors.initials: BP
authors.lastname: van Putte
authors.forename: Jeroen M H
authors.initials: JM
authors.lastname: Hendriks
authors.forename: Paul E Y
authors.initials: PE
authors.lastname: Van Schil
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects*; D010478:Chemotherapy, Cancer, Regional Perfusion; D006801:Humans; D006979:Hyperthermia, Induced; D008137:Longitudinal Studies; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects*; D011300:Preoperative Care
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan